ARCHIVES

Peters Leaves NCI For CF Foundation

This article is from The Cancer Letter archive.

Vol. 04 No. 05 | February 3, 1978

Download PDF Visit The Full Archive

Related Articles

Novel Antifungal Agent Highly Active Against Esophageal Candidiasis

October 31, 2003

In Brief: Spitz elected President, ASPO: Karmanos Received $6 Million From Chrysler, Ford

May 30, 1997

FDA Advisors Recommend Approval Of Topotecan for Ovarian Cancer

April 26, 1996

Schweiker Approves Chabner Appointment

September 10, 1982

AACI Told Medicare “Probably” Has Paid For Extra Patient Care Costs Of Research; Members Object To “Two Level System”

July 27, 1984

NCI Tells CCOPs To Slow Patient Accrual To Clinical Trials, Prepare For Budget Cuts.

May 12, 2006